“…EGFR plays an important role in numerous processes that affect cell cycle progression which leads to tumor development, growth, progression, differentiation and development of metastasis. [ 11 ] In many studies, it has been shown to correlate with a poor prognosis[ 12 13 ] and also resistance to radiotherapy in a variety of cancers, especially SCC. [ 14 ] Therefore, this study has been undertaken to evaluate the expression of EGFR in HNSCC cases and find its association with various pathological prognostic factors including grade, stage and lymph node metastasis, hoping that these findings could provide prognostic assessment of the disease and help in designing more appropriate and effective treatment strategies for OSCC.…”